Back to search

Article

Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019

2022-03-10

Abstract excerpt

<h4>Objective</h4> Conflict of interest with pharmaceutical companies is one of the most contentious issues in infectious diseases. However, there is a lack of whole picture of detailed payments in Japan. <h4>Study Design and Setting</h4> This retrospective study assessed financial relationships between pharmaceutical companies and all infectious disease specialists board-certified by the Japanese Association for...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9c8421a6-13b6-5204-a862-049bfb40b034
DOI
10.1101/2022.03.09.22271972
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019DOI 10.1101/2022.03.09.22271972
Nature and Trends of Pharmaceutical Payments to the Board Certified Respiratory Specialists in Japan between 2016 and 2019Semantic proximity
Financial conflicts of interest among authors of clinical practice guideline for headache disorders and board-certified neurologists in JapanSemantic proximity
Industry payments to anesthesiologists in the United States between 2014 and 2022Semantic proximity
Financial Conflicts of Interest among U.S. Physician Authors of 2020 Clinical Practice Guidelines: A Cross-Sectional StudySemantic proximity
Rare Disease Curative Care Expenditure- Financing Scheme-Health Provider- Beneficiary Group Analysis — An Empirical Study in Sichuan Province, ChinaSemantic proximity
Cross-sectional analysis of Open payments for physicians at designated hemophilia centers in the US (2018-2020)Semantic proximity
Characterizing industry payments to ophthalmologists before and after onset of the COVID-19 pandemicSemantic proximity
The Urgent Need to Empower Rare Disease Organizations in China: An Interview-Based StudySemantic proximity
Evaluation of non-research and research industry payments to pediatric hematologist/oncologists in the United States between 2013 and 2021Semantic proximity
The Allocation of US$ 105 Billion in Global Funding for Infectious Disease Research between 2000 and 2017: An Analysis of Investments from Funders in the G20 CountriesSemantic proximity
Awareness and perceptions among members of a Japanese cancer patient advocacy group concerning the financial relationships between the pharmaceutical industry and physicians: a mixed-methods analysis of survey dataSemantic proximity
The Direct Economic Disease Burden of Healthcare-associated Infections (HAIS) and Antimicrobial Resistance (AMR): A Preliminary Study in a Teaching Hospital of NepalSemantic proximity
Select a neighboring publication to make it the new centre.